Mon.Jul 22, 2024

article thumbnail

STAT+: Express Scripts overcharged postal workers by $45 million, audit says

STAT

Express Scripts, one of the largest pharmacy benefit managers in the country, overcharged U.S. Postal Service employees by a whopping $45 million for their prescription drugs during a recent five-year period, according to a federal audit. The findings are likely to intensify scrutiny of the controversial role played by PBMs in the opaque pharmaceutical pricing system.

article thumbnail

To overcome barriers, cell and gene therapies need outside support

PharmaVoice

With great potential in cell and gene therapies, there are still plenty of barriers to getting the breakthroughs to patients.

148
148
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bird flu that infected 6 Colorado poultry workers is closely related to the virus in cows

STAT

Bird flu snapshot: This is the latest installment in a series of regular updates on H5N1 avian flu that STAT is publishing on Monday mornings. To read future updates, you can also subscribe to STAT’s Morning Rounds newsletter. Public health experts who’ve been following the surprising spillover of H5N1 bird flu into America’s dairy cattle herds now have all eyes on Colorado, waiting to see if a cluster of human cases there might balloon into something bigger.

362
362
article thumbnail

How NVIDIA grew with the healthcare market instead of pushing into it

Pharmaceutical Technology

As the use of AI soared across healthcare, NVIDIA fit the bill in providing the necessary technology – and its stock tells the same story.

137
137
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Q&A: Trans adults face ‘shocking’ risk of cirrhosis, especially alcohol-driven

STAT

People under 45 have been driving an increase in liver-related deaths, especially those caused by alcohol. But a sliver of that young adult population is being hit disproportionately hard by alcohol-associated liver disease: transgender people. Although trans adults make up less than 1% of the United States population, a study published in The American Journal of Gastroenterology last month shows they face double the risk of severe liver disease, and a higher share of cirrhosis from heavy drinki

350
350
article thumbnail

Ionis plots next steps for Angelman drug Biogen passed on

BioPharma Dive

The company plans to start a late-stage study next year, after a smaller trial found its drug offered “robust and consistent” benefits on communication, cognition and motor function.

More Trending

article thumbnail

New study shows wearable trackers provide clinical use for heart disease patients

Pharma Times

Cardiovascular disease, including coronary heart disease, currently affects around seven million people in the UK

131
131
article thumbnail

Opinion: NIDA should beware of funding companies that violate people’s privacy

STAT

In a ground-breaking settlement with the Federal Trade Commission, two online addiction and mental health treatment companies, Monument and Cerebral , admitted to deceptively and widely sharing sensitive personal and health information with third-party advertising platforms including Meta (Facebook) and Google. They aren’t alone. Our research at the Opioid Policy Institute has found more than a dozen other online addiction treatment companies engaging in similar deceptive behavior that co

344
344
article thumbnail

Applying intercultural intelligence to promote growth in the Middle East

pharmaphorum

Learn how applying intercultural intelligence can promote growth and success in the dynamic and diverse business environment of the Middle East. Gain insights and strategies for effective cross-cultural communication and collaboration.

article thumbnail

STAT+: Medicare and Medicaid struggles foreshadow a rocky health insurer earnings season

STAT

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday. Express Scripts overcharged your mail carrier Express Scripts, one of the largest pharmacy benefit managers in the country, overcharged U.S. Postal Service employees by a whopping $45 million for their prescription drugs during a recent five-year period, according to an under-the-radar federal audit that my colleague Ed

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

From Classroom to Community: My Eye-Opening Rotation at a CPESN Pharmacy

Flip the Pharmacy

Currently, I am a first year (P1) pharmacy student at Palm Beach Atlantic University’s Lloyd L. Gregory School of Pharmacy in West Palm Beach, Florida. Before starting my first Introductory Pharmacy Practice Experience (IPPE) rotation, I had no idea what to expect. I had some experience in a chain pharmacy, so I had a general understanding of community pharmacy operations.

article thumbnail

STAT+: Pharmalittle: We’re reading about Express Scripts overcharging postal workers, Gilead’s AIDS drug price, and more

STAT

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-so familiar routine of online meetings, phone calls, and deadlines has predictably returned. But what can you do? The world, such as it is, continues to spin. So time to give it a nudge in a better direction with a cup or two of stimulation.

article thumbnail

SynaptixBio collaborates with Evotec to boost search for rare disease therapies

Express Pharma

SynaptixBio, a company licensed to commercialise a treatment for a rare, incurable and deadly disease, has announced its collaboration with Evotec, to find further candidate drugs to treat H-ABC, the most severe form of TUBB4A leukodystrophy. Drug research was originally carried out by the Children’s Hospital of Philadelphia (CHOP), the world’s leading centre for leukodystrophy research, under a sponsored research agreement.

Hospitals 102
article thumbnail

STAT+: European Commission reaches deal with Vifor for ‘disparaging’ its only rival in iron deficiency market

STAT

Following a two-year probe, the European Commission has formalized a proposal from Vifor Pharma to resolve allegations that the company spread misleading information about a rival treatment to its blockbuster drug for iron deficiency. The move came after a complaint that Vifor may have disparaged its “closest and, potentially, only” competitor to its Ferinject medicine in the European market.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Private biotech M&A surges amid difficult IPO market

BioPharma Dive

Private biotech company acquisitions are on their fastest pace in years, a trend some in the industry say is driven by the abundance of mature, but not yet public, drug startups.

101
101
article thumbnail

Smoking linked to cognitive decline in older adults

The Pharmacist

Smoking may be the key lifestyle factor that determines how quickly cognitive decline occurs in older adults, research suggests. Memory and fluency in older adults declined by up to 85% more over a 10-year period in smokers compared to non-smokers. The study, which was undertaken by researchers at University College London (UCL), looked at 16 […] The post Smoking linked to cognitive decline in older adults appeared first on The Pharmacist.

98
article thumbnail

Action by FDA ensures trial sponsors must consider diversity

pharmaphorum

The recent action by the FDA mandates that trial sponsors must consider diversity in clinical trials. Learn more about the importance of diversity and inclusion in medical research.

101
101
article thumbnail

How NIVIDIA grew with the healthcare market instead of pushing into it

Pharmaceutical Technology

As the use of AI soared across healthcare, NVIDIA fit the bill in providing the necessary technology – and its stock tells the same story.

98
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Study finds wearables deliver key insights in heart disease

pharmaphorum

Consumer wearables have shown a benefit when used to monitor treatment responses in patients with atrial fibrillation and heart failure.

109
109
article thumbnail

Breakthroughs in immunotherapy: glycoproteins as predictive biomarkers for therapeutic response

BioPharma Dive

Serum-based glycoproteins demonstrate success in predicting immune checkpoint inhibitor therapy outcomes.

article thumbnail

Study points to route for 'one and done' flu vaccine

pharmaphorum

Scientists at OHSU in the US have developed a universal form of influenza vaccine that they say could protect against all strains of the virus

Vaccines 108
article thumbnail

Trial investigates faecal microbiota transplantation to treat rare liver disease

Pharma Times

Primary sclerosing cholangitis is estimated to affect one in 100,000 people worldwide annually

110
110
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Valneva gets $41m grant to roll out chikungunya vaccine

pharmaphorum

Valneva has been awarded funding from the Coalition for Epidemic Preparedness Innovations (CEPI) and EU to expand access to its recently approved vaccine for chikungunya, a potentially life-threatening mosquito-borne disease.

article thumbnail

EMA accepts GSK’s Blenrep MAA for multiple myeloma for review

Pharmaceutical Technology

The EMA has accepted for review GSK’s MAA for Blenrep for relapsed or refractory multiple myeloma (r/r MM).

93
article thumbnail

Grünenthal buys Valinor and constipation drug for $250m

pharmaphorum

Pain medicine specialist Grünenthal has agreed to buy Valinor Pharma for $250m, getting control of Movantik for opioid-induced constipation

107
107
article thumbnail

US government declines to clear Bluebird fertility support for Zynteglo patients

BioPharma Dive

The Health and Human Services' inspector general issued a "negative opinion" on Bluebird's request one week after Vertex sued the federal government over access to fertility preservation services.

67
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

In conversation with Chris Moore: Declining HCP access

pharmaphorum

Web editor Nicole Raleigh sat down with Chris Moore, president of Europe for Veeva Systems, to discuss the global trend in declining HCP access and how a more coordinated approach across functions can help.

92
article thumbnail

Cracking the Biosimilar Code: A Deep Dive into Effective IP Strategies

Drug Patent Watch

In the rapidly evolving landscape of biosimilars, intellectual property (IP) strategy is paramount.

article thumbnail

Rare Disease Diagnostics: Advancing Orphan Drug Development through Precision Testing

pharmaphorum

Rare Disease Diagnostics: Advancing Orphan Drug Development through Precision Testing Mike.

article thumbnail

Pharmacies ‘paying the price’ for IT outage

The Pharmacist

Challenges caused by last week’s IT outages have only added to the pressures community pharmacy teams already face, The Pharmacist has been told. Community Pharmacy England (CPE) has confirmed that the issues, which affected GP and pharmacy systems and patient records access, have now been 'resolved on the whole’. But community pharmacy teams are still […] The post Pharmacies ‘paying the price’ for IT outage appeared first on The Pharmacist.

article thumbnail

Innovent throws its hat further into China's GLP-1 ring

pharmaphorum

Innovent Biologics is planning a second filing for its dual GLP-1/glucagon agonist mazdutide in China, as it tries to carve out a share of a market currently dominated by Novo Nordisk and Eli Lilly.Mazdutide – a once-weekly injectable Innovent licensed from Lilly – was submitted to China's National Medical Products Administration (NMPA) earlier this year for weight management in overweight and obesity, and will soon be submitted for type 2 diabetes as well after a second positive phase 3 trial,